W
Women's Health Care Research | San Diego, CA
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Estradiol
Fluconazole
Drospirenone
LF111
SYM-1219
Elagolix
Vagifem
SCY-078
Ibrexafungep
LevoCept
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
4 of 26 total trials
To assess the contraceptive efficacy (prevention of pregnancy) of VeraCept
Active, not recruiting
Women at Risk for Pregnancy
Drug: VeraCept
To assess the contraceptive efficacy (prevention of pregnancy) of LevoCept
Begins enrollment in 2 months
Contraception
Women at Risk for Pregnancy
Drug: LevoCept
The primary objective of this study is to evaluate the impact of LF111 and drospirenone (DRSP) 3.5 mg chewable tablets on bone mineral density (BMD)...
Enrolling
Change in Bone Mineral Density
Bone Loss
Drug: LF111 (drospirenone 4 mg oral tablet) or drospirenone (DRSP) 3.5 mg chewable tablet
Study of the contraceptive efficacy, cycle control, safety, and tolerability of MR-100A-01 in approxmiately 1200 women for up to 13 cycles
Active, not recruiting
Contraception
Drug: MR-100A-01
Trial sponsors
C
S
S
T
A
I
L
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems